Mission & Strategy

Eckert & Ziegler BEBIG’s mission is to develop and provide the customers around the world with innovative medical devices for the effective treatment of cancer while preserving the patient's quality of life. Through on-time delivery, consistent high quality, flexible manufacturing processes and constant self-improvement, we strive to meet the needs of our customers and the expectations of our investors. We also commit to meet all regulatory requirements and maintain an effective quality system. To further grow our company, we are constantly working on the development of future innovative products.


Eckert & Ziegler BEBIG has strengthened and expanded its core business continuously in recent years. We want to continue along this path. Our strategy to do so consists of six points:

Coverage of the Entire Process and Supply Chain

Eckert & Ziegler BEBIG covers all the essential parts of the process and supply chain. This includes research and development, production, quality assurance and distribution. It is important for us to maintain the high quality standards of our own products as well as those purchased and to continuously improve them as required. Made in Germany is not just a slogan; for us it's an obligation.

Further Internationalization

Following the successful entry into key European markets, Eckert & Ziegler BEBIG shall now focus on continuing to expand its position in the USA, in Asia and in South America. This will take place via approvals of our products and the expansion of distribution structures.

Demand-capacity Allocation

In view of the ongoing and future growth of the global markets for radiotherapy, Eckert & Ziegler BEBIG has allocated our production expansion between two locations (Germany and USA). Eckert & Ziegler BEBIG has thereby created the conditions to maintain and expand its market position, and to continue to grow.